![Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study - Atherosclerosis Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study - Atherosclerosis](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/863221/6312061/gr1.gif)
Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study - Atherosclerosis
Summary and Introduction Comparison of the Efficacy of Rosuvastatin vs Atorvastatin (printer-frie... http://www.medscape.com/vie
![Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients](https://static-01.hindawi.com/articles/isrn/volume-2013/146579/figures/146579.fig.001.jpg)
Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
![Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups - American Journal of Cardiology Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5cbf2f81-81fc-4914-a940-ad434af41a63/gr1.gif)
Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups - American Journal of Cardiology
![Treatment Failure With Atorvastatin After Change From Rosuvastatin to Atorvastatin | Federal Practitioner Treatment Failure With Atorvastatin After Change From Rosuvastatin to Atorvastatin | Federal Practitioner](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_027_FP1215_T4.jpg.jpg)
Treatment Failure With Atorvastatin After Change From Rosuvastatin to Atorvastatin | Federal Practitioner
![Preferred dosages of atorvastatin and rosuvastatin for ascVD and DM... | Download Scientific Diagram Preferred dosages of atorvastatin and rosuvastatin for ascVD and DM... | Download Scientific Diagram](https://www.researchgate.net/profile/David-Waters-3/publication/278793426/figure/fig2/AS:391845004759051@1470434537710/Preferred-dosages-of-atorvastatin-and-rosuvastatin-for-ascVD-and-DM-management-Notes.png)
Preferred dosages of atorvastatin and rosuvastatin for ascVD and DM... | Download Scientific Diagram
![Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients](https://static-01.hindawi.com/articles/isrn/volume-2013/146579/figures/146579.fig.003.jpg)
Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
|3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35|36 |37 |38 |39 |40 |review Key Point: After 6 weeks of treatment in the STELLAR trial, a significantly greater percentage of patients treated with ...
![Comparison of the efficacy and safety of rosuvastatin versus atorvastatin in reduction of low density lipoprotein cholesterol in patients of type 2 diabetes mellitus with dyslipidemia | Semantic Scholar Comparison of the efficacy and safety of rosuvastatin versus atorvastatin in reduction of low density lipoprotein cholesterol in patients of type 2 diabetes mellitus with dyslipidemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b6d5b5912f98294aa4a4ccfa1d64a883babac4f4/3-Figure1-1.png)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin in reduction of low density lipoprotein cholesterol in patients of type 2 diabetes mellitus with dyslipidemia | Semantic Scholar
![Figure 58 from Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol | Semantic Scholar Figure 58 from Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4233f4c81ae1eafc84d15a88e81847590b6349ed/4-Table2-1.png)
Figure 58 from Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol | Semantic Scholar
![a) Rosuvastatin versus other statins, (b) Comparison of patients with... | Download Scientific Diagram a) Rosuvastatin versus other statins, (b) Comparison of patients with... | Download Scientific Diagram](https://www.researchgate.net/profile/Abdulbari-Bener/publication/260169709/figure/fig1/AS:614182156267543@1523443845441/a-Rosuvastatin-versus-other-statins-b-Comparison-of-patients-with-pre-and.png)
a) Rosuvastatin versus other statins, (b) Comparison of patients with... | Download Scientific Diagram
![Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients](https://static-01.hindawi.com/articles/isrn/volume-2013/146579/figures/146579.fig.002.jpg)
Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
![Ezetimibe/statin combination therapy more effective in LDL-c lowering than statin uptitration - PACE-CME Ezetimibe/statin combination therapy more effective in LDL-c lowering than statin uptitration - PACE-CME](https://pace-cme.org/2013/11/26/ezetimibe-statin-combination-therapy-more-effective-in-ldl-c-lowering-than-statin-uptitration/images/Ezetimibe-statin-combination-therapy-more-effective-in-LDL-c-lowering-than-statin-uptitration-2x.png)
Ezetimibe/statin combination therapy more effective in LDL-c lowering than statin uptitration - PACE-CME
![Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia - ScienceDirect Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S075333222031372X-ga1.jpg)
Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia - ScienceDirect
![Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6a2d30c7-9c77-4b5b-9d83-009bb8831a1a/gr1_lrg.jpg)
Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg
|2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |review Key Point: In the STELLAR trial, the 10-mg dose of rosuvastatin lowered LDL-C more effectively than atorvastatin ...
|35 |36 |37 |38 |39 |40 |41 |42 |43 |44 |45 |46 |47 |48 |49 |50 |51 |review Key Point: Across the dose range, rosuvastatin and atorvastatin reduced TG to a similar extent. Dose for dose, there were no significant differences in reductions in TG levels from baseline ...
![Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial) - American Journal of Cardiology Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial) - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2005024254/2021360392/gr5.jpg)